Stock Watch: Different Regulators Bare Their Teeth At Biotech
Illumina May Not Be the Only Buyer To Face Barriers
When the sector worries about regulation it is usually about drug development and registration. But governments also regulate on monopolistic positions in life sciences. Adding to that, national security enforcement is now rising.